| TITLE |
DATE |
| Illumina to Present at the Piper Jaffray Health Care Conference |
23-Nov-2011 |
| Illumina Names Dr. Daniel S. Grosu Chief Medical Officer |
31-Oct-2011 |
| Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats |
12-Oct-2011 |
| Illumina Introduces Revolutionary Workflow Enhancements for MiSeq(TM) |
11-Oct-2011 |
| Illumina Enters Collaborative Research Agreement with UNTHSC for Next-Generation Sequencing in Forensic DNA Analysis |
4-Oct-2011 |
| Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle |
29-Sep-2011 |
| Illumina to Webcast Live Presentations at Upcoming Investment Conferences in September |
7-Sep-2011 |
| Illumina Announces New $100 Million Share Repurchase Authorization |
3-Aug-2011 |
| Illumina and University of Oxford to Sequence 500 Whole Human Genomes for Rare Disease Research |
3-Aug-2011 |
| Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable |
27-Jul-2011 |
| Illumina Reports Financial Results for Second Quarter 2011 |
26-Jul-2011 |
| Illumina Announces First Customer Shipments of the Omni5 BeadChip |
25-Jul-2011 |
| Illumina Selected as a Preferred Service Provider for Cancer Research UK |
14-Jul-2011 |
| Illumina Introduces TruSeq(TM) Custom Enrichment Kits for Next
Generation Sequencing |
13-Jul-2011 |
| Illumina to Announce Second Quarter 2011 Financial Results on Tuesday, July 26, 2011 |
12-Jul-2011 |
| University of Washington Department of Genome Sciences Joins Illumina Genome Network |
29-Jun-2011 |
| Illumina Announces Bold Steps to Accelerate the Adoption of Individual Genome Sequencing |
8-Jun-2011 |
| Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June |
31-May-2011 |
| Illumina Reduces Price of Whole Human Genome Sequencing Through Illumina Genome Network |
9-May-2011 |
| Illumina to Present at Upcoming Investment Conferences in May |
26-Apr-2011 |
| Illumina to Announce First Quarter 2011 Financial Results on Tuesday,
April 26, 2011 |
12-Apr-2011 |
| Illumina Closes $800 Million Convertible Senior Notes |
18-Mar-2011 |
| Illumina Prices $800 Million Convertible Senior Notes |
15-Mar-2011 |
| Illumina to Offer $800 Million Convertible Senior Notes |
14-Mar-2011 |
| Illumina to Present at Upcoming Investment Conferences in March |
2-Mar-2011 |
| Illumina to Announce Fourth Quarter and Fiscal Year 2010 Financial Results on Tuesday, February 8, 2011 |
25-Jan-2011 |
| Illumina to Open Latin America Office |
18-Jan-2011 |
| Illumina Launches the Illumina Agricultural Greater Good Initiative to Help Reduce Global Hunger, Malnutrition and Poverty |
18-Jan-2011 |
| Illumina Acquires Epicentre Biotechnologies, Leading Provider of Nucleic Acid Sample Preparation Reagents and Specialty Enzymes |
11-Jan-2011 |
| Illumina Announces MiSeq(TM) Personal Sequencing System |
11-Jan-2011 |
| Illumina Announces Preliminary Financial Results for Fourth Quarter 2010 |
11-Jan-2011 |
| Illumina Introduces the Next Generation of iSelect(R) Custom Genotyping |
10-Jan-2011 |
| Illumina to Present at J.P. Morgan Healthcare Conference |
4-Jan-2011 |
| Illumina to Present at Upcoming Investment Conferences in November |
9-Nov-2010 |
| Illumina Introduces TruSeq(TM) Sample Prep and Exome Enrichment Kits |
3-Nov-2010 |
| Illumina Announces HiSeq 1000 Sequencing System |
26-Oct-2010 |
| Illumina to Announce Third Quarter 2010 Financial Results on Tuesday, October 26, 2010 |
12-Oct-2010 |
| Illumina and Wellcome Trust Sanger Institute Announce Completed Genome for Endangered Tasmanian Devil |
15-Sep-2010 |
| Illumina to Present at Upcoming Investment Conferences in September |
7-Sep-2010 |
| Illumina Announces Creation of the Illumina Genome Network |
27-Jul-2010 |
| Illumina Announces Launch of the Eco(TM) Real-Time PCR System |
27-Jul-2010 |
| Illumina Reports Financial Results for Second Quarter 2010 |
27-Jul-2010 |
| Illumina Announces New TruSeq(TM) SBS Sequencing Kit for the Genome Analyzer |
26-Jul-2010 |
| Illumina Announces Appointment of Melina Cimler as Vice President,
Quality and Regulatory Affairs |
16-Jul-2010 |
| Illumina to Announce Second Quarter 2010 Financial Results on
Tuesday, July 27, 2010 |
14-Jul-2010 |
| Illumina Names Gerald Möller to Board of Directors |
7-Jul-2010 |
| Illumina Appoints Nicholas Naclerio Senior Vice President, Corporate Development |
2-Jul-2010 |
| Illumina to Present at Goldman Sachs Global Healthcare Conference |
9-Jun-2010 |
| Illumina Announces Purchase of HiSeq(TM) 2000 Units by the Broad Institute |
7-Jun-2010 |
| Illumina Announces New Pricing for its Individual Genome Sequencing Service |
3-Jun-2010 |
| Illumina Announces First Customer Shipments of Omni2.5 BeadChip |
2-Jun-2010 |
| Illumina Receives FDA 510(k) Clearance for VeraCode(R) Genotyping Test for Factor V (Leiden) and Factor II (Prothrombin) |
18-May-2010 |
| Illumina Receives FDA 510(k) Clearance for Its BeadXpress(R) Multiplex Analysis System |
4-May-2010 |
| Illumina Announces Appointments of Elizabeth Brady as Vice President, Global Supply Chain, and Emily Winn-Deen as Vice President, Diagnostics Development |
30-Apr-2010 |
| Illumina Reports Financial Results for First Quarter 2010 |
28-Apr-2010 |
| Illumina Now Shipping HiScan(TM)SQ Platform |
27-Apr-2010 |
| Illumina to Present at Upcoming Investment Conferences in May |
27-Apr-2010 |
| Illumina Announces Its First Full Coverage DNA Sequencing of a Named
Family |
16-Apr-2010 |
| Illumina to Announce First Quarter 2010 Financial Results on Wednesday, April 28, 2010 |
14-Apr-2010 |
| Illumina Introduces VeraCode(R) ADME Core Panel for Pharmaceutical Research |
7-Apr-2010 |
| Illumina Announces HumanOmniExpress+ Custom BeadChip |
16-Mar-2010 |
| Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female |
11-Mar-2010 |
| Illumina to Present at Upcoming Investment Conferences in March |
3-Mar-2010 |
| Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2009 |
4-Feb-2010 |
| Illumina to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Thursday, February 4, 2010 |
21-Jan-2010 |
| Illumina Introduces Genome AnalyzerIIe Sequencing System |
14-Jan-2010 |
| BGI Purchases 128 Illumina HiSeq(TM) 2000 Sequencing Systems |
12-Jan-2010 |
| Illumina Announces HiSeq(TM) 2000 Sequencing System |
12-Jan-2010 |
| Illumina Introduces the HumanOmniExpress BeadChip |
11-Jan-2010 |
| Illumina Launches High-Density Bovine BeadChip |
7-Jan-2010 |
| Illumina Announces Upcoming Webcasts in the Month of January |
5-Jan-2010 |
| Illumina Announces $100 Million Share Repurchase Program |
25-Nov-2009 |
| Illumina to Present at the Piper Jaffray "Unplugged" Health Care Conference |
25-Nov-2009 |
| Illumina Announces Scale-Up of Genome Analyzers at The Broad Institute |
5-Nov-2009 |
| Illumina Reports Financial Results for Third Quarter 2009 |
27-Oct-2009 |
| Illumina Announces Roadmap to Five Million Variants for Next-Generation Whole-Genome Genotyping |
21-Oct-2009 |
| Illumina Launches cBot, a Breakthrough Workflow Automation System for Next Generation Sequencing |
20-Oct-2009 |
| Illumina Countersues Life Technologies for Patent Infringement |
14-Oct-2009 |
| Illumina to Announce Third Quarter 2009 Financial Results on Tuesday, October 27, 2009 |
14-Oct-2009 |
| Illumina Announces Fully Integrated High-Performance Computing for Sequencing Customers |
6-Oct-2009 |
| Life Technologies Initiates Suit Against Illumina Alleging Patent Infringement |
23-Sep-2009 |
| Illumina to Present at Upcoming Investment Conferences in September |
3-Sep-2009 |
| Illumina Announces Delivery of the First Genome Through Its Individual Genome Sequencing Service |
31-Aug-2009 |
| Illumina Announces $75 Million Share Repurchase Program |
24-Aug-2009 |
| Illumina Appoints Christian Henry to Newly Created Position of Senior Vice President of Corporate Development |
18-Aug-2009 |
| Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers to Expand Capacity for Asian 100 Genome Project |
22-Jul-2009 |
| Illumina Reports Financial Results for Second Quarter 2009 |
21-Jul-2009 |
| Illumina to Announce Second Quarter 2009 Financial Results on Tuesday, July 21, 2009 |
7-Jul-2009 |
| Illumina Launches Multi-Sample Indexing for GoldenGate(R) Assay |
2-Jul-2009 |
| Illumina Announces Preliminary Revenue for Second Quarter 2009 |
1-Jul-2009 |
| Illumina Announces Personal Genome Sequencing Service |
10-Jun-2009 |
| Illumina to Present at the Goldman Sachs Global Healthcare Conference |
3-Jun-2009 |
| Illumina Introduces the Infinium(R) HD HumanOmni1-Quad BeadChip |
18-May-2009 |
| Illumina to Present at Upcoming Investment Conferences in May |
6-May-2009 |
| Illumina Introduces Breakthrough Software Advancements with Genome AnalyzerIIx Sequencing System |
6-May-2009 |
| Illumina Files Patent Infringement Suit Against Affymetrix |
5-May-2009 |
| Illumina Reports Financial Results for First Quarter 2009 |
21-Apr-2009 |
| BGI Purchases an Additional 12 Illumina Genome Analyzers, Expanding Their Shenzhen and Hong Kong Branches |
20-Apr-2009 |
| Illumina and Agilent Technologies to Co-Market Targeted Resequencing Solution |
20-Apr-2009 |
| Illumina Announces Scale-Up of its Genome Analyzer Sequencing Technology at The Broad Institute of MIT and Harvard |
16-Apr-2009 |
| Illumina to Announce First Quarter 2009 Financial Results on Tuesday, April 21, 2009 |
7-Apr-2009 |
| Illumina to Present at Upcoming Investment Conferences in March |
4-Mar-2009 |
| The Genome Center at Washington University Scales-Up on Illumina Sequencers |
6-Feb-2009 |
| Illumina Presents Development Roadmap for Scaling its Genome Analyzer |
5-Feb-2009 |
| Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2008 |
3-Feb-2009 |
| Forbes Names Illumina America's Fastest-Growing Technology Company for Second Time |
30-Jan-2009 |
| Illumina Launches Suite of Next-Generation Sequencing Kits |
27-Jan-2009 |
| Illumina to Announce Fourth Quarter and Fiscal Year 2008 Financial Results on Tuesday, February 3, 2009 |
20-Jan-2009 |
| Illumina Announces High Density Expansion to iSelect(R) Custom Genotyping Platform |
13-Jan-2009 |
| Illumina Genome Analyzer Selected by Internationally Recognized Medical Center to Sequence 50 Human Genomes |
12-Jan-2009 |
| Illumina and Oxford Nanopore Enter into Broad Commercialization Agreement |
12-Jan-2009 |
| Illumina Announces Certified Service Provider Program for Sequencing and Names First Participating Organizations |
9-Jan-2009 |
| Chinese Researchers Sequence World's First Giant Panda Genome |
9-Jan-2009 |
| Expression Analysis (EA) Purchases Its First Illumina Genome Analyzer |
8-Jan-2009 |
| Illumina to Present at the J.P. Morgan Healthcare Conference |
5-Jan-2009 |
| Illumina Appoints Bill Bonnar Senior Vice President of Operations |
5-Jan-2009 |
| CORRECTING and REPLACING Illumina Added to NASDAQ-100 Index |
15-Dec-2008 |
| Illumina Added to NASDAQ-100 Index |
15-Dec-2008 |
| Illumina Appoints Mark Lewis Senior Vice President of Development |
15-Dec-2008 |
| Illumina to Present at the Piper Jaffray Health Care Conference |
25-Nov-2008 |
| The Wellcome Trust Sanger Institute Continues Scale Up with Order for 11 Additional Illumina Genome Analyzers |
13-Nov-2008 |
| Illumina Launches Infinium HD Human660W-Quad BeadChip for Advancing Copy Number Variation Analysis Studies |
12-Nov-2008 |
| Illumina Announces Breakthrough Human Genome Sequencing Studies Published in Nature |
7-Nov-2008 |
| Illumina Launches the HumanCytoSNP-12 BeadChip |
6-Nov-2008 |
| Illumina to Webcast Analyst Day on November 6, 2008 |
30-Oct-2008 |
| Illumina Announces $120 Million Share Repurchase Program |
24-Oct-2008 |
| Illumina Reports Financial Results for Third Quarter 2008 |
21-Oct-2008 |
| Illumina Launches GenomeStudio(TM) Data Analysis Software |
20-Oct-2008 |
| Illumina Launches mRNA-Seq on the Genome Analyzer |
9-Oct-2008 |
| Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies |
9-Oct-2008 |
| Illumina to Announce Third Quarter 2008 Financial Results on Tuesday, October 21, 2008 |
8-Oct-2008 |
| Illumina Announces 2-for-1 Stock Split |
10-Sep-2008 |
| Illumina to Present at Upcoming Investment Conferences in September |
28-Aug-2008 |
| Illumina Announces Completion of Public Offering of Common Stock |
12-Aug-2008 |
| Illumina Announces Pricing of its Public Offering of Common Stock |
7-Aug-2008 |
| Illumina Announces 3.5 Million Share Public Offering |
4-Aug-2008 |
| Illumina Appoints Mostafa Ronaghi as Senior Vice President and Chief Technology Officer |
4-Aug-2008 |
| Illumina to Present at the Leerink Swann Life Science Tools Roundtable Conference |
31-Jul-2008 |
| GeneSeek Becomes Illumina's First Certified Service Provider to Use Infinium DNA Analysis BeadChips for Agriculture Research |
28-Jul-2008 |
| Illumina Reports Financial Results for Second Quarter 2008 |
22-Jul-2008 |
| Illumina Appoints Stephen Pentoney as Vice President of Array Biochemistry |
21-Jul-2008 |
| Illumina to Announce Second Quarter 2008 Financial Results on Tuesday, July 22, 2008 |
8-Jul-2008 |
| The Wellcome Trust Case Control Consortium (WTCCC) Selects Illumina Infinium High-Density (HD) DNA Analysis Products to Study 90,000 Samples |
1-Jul-2008 |
| Illumina Appoints Fredrick Clerie as Vice President of Quality Assurance and Regulatory Affairs |
23-Jun-2008 |
| Illumina Announces LIFE & BRAIN as Germany's First Certified Genetic Analysis Service Provider |
20-Jun-2008 |
| Illumina Announces Mitsubishi Chemical Safety Institute as Japan's First Certified Genetic Analysis Service Provider |
19-Jun-2008 |
| Illumina to Present at the Piper Jaffray Europe Conference |
19-Jun-2008 |
| Illumina Announces Participation in the 1000 Genomes Project |
11-Jun-2008 |
| National Geographic Channel's Documentary, Explorer: Science of Cats, Features Illumina's(R) VeraCode(R) Technology |
9-Jun-2008 |
| Illumina to Present at the Goldman Sachs 29th Annual Global Healthcare Conference |
4-Jun-2008 |
| Illumina Completes Sequencing of African Trio |
6-May-2008 |
| Illumina and Genpathway Announce Partnership to Provide Whole-Genome ChIP-Sequencing Services |
30-Apr-2008 |
| Illumina to Present at Upcoming Investment Conferences in May |
29-Apr-2008 |
| Illumina Reports Financial Results for First Quarter 2008 |
22-Apr-2008 |
| Beijing Genomics Institute Signs Multi-Million Dollar Order for 11 Additional Illumina Genome Analyzers |
22-Apr-2008 |
| Illumina Announces the HumanHT-12 Gene Expression BeadChip |
21-Apr-2008 |
| CORRECTING and REPLACING Illumina Launches the iScan(TM) System |
18-Apr-2008 |
| Illumina Launches the iScan(TM) System |
14-Apr-2008 |
| Illumina Introduces Three New Research Products to Study Genetic Variations Linked to Cancer Development |
11-Apr-2008 |
| Illumina to Announce First Quarter 2008 Financial Results on Tuesday, April 22, 2008 |
8-Apr-2008 |
| Illumina Appoints Mike Bouchard as Vice President of Finance |
24-Mar-2008 |
| Illumina Appoints Joel McComb as Senior Vice President and General Manager of Life Sciences and Gregory F. Heath as Senior Vice President and General Manager of Diagnostics |
17-Mar-2008 |
| Illumina to Present at Investment Conferences in March 2008 |
6-Mar-2008 |
| Illumina Sequences the First African Human Genome |
6-Feb-2008 |
| Illumina Revises 2008 GAAP EPS Guidance |
5-Feb-2008 |
| Illumina Reports Financial Results for Fourth Quarter and Fiscal 2007 |
4-Feb-2008 |
| Illumina to Present at Upcoming Investment Conferences in the Month of February |
30-Jan-2008 |
| Illumina Announces Multi-Million Dollar Agreement with Erasmus Medical Center |
23-Jan-2008 |
| Illumina to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on Monday, February 4, 2008 |
21-Jan-2008 |
| Illumina Announces Commercial Release of the Infinium(R) BovineSNP50 BeadChip |
15-Jan-2008 |
| Affymetrix and Illumina Settle Their Patent Disputes |
10-Jan-2008 |
| Illumina Introduces the Infinium(R) High-Density (HD) Human1M-Duo and Human610-Quad BeadChips |
7-Jan-2008 |
| Illumina Announces Corporate Reorganization |
4-Jan-2008 |
| Illumina to Present at the 2008 JPMorgan Healthcare Conference in San Francisco |
31-Dec-2007 |
| The United States Patent and Trademark Office Orders The Re-Examination of Two Additional Patents Included in the Patent Litigation Between Illumina and Affymetrix |
21-Dec-2007 |
| The United States Patent and Trademark Office Orders the Re-Examination of Two Patents Included in the Patent Litigation between Illumina and Affymetrix |
21-Dec-2007 |
| Illumina to Present at the 2007 Piper Jaffray Healthcare Conference in New York City |
22-Nov-2007 |
| Illumina Introduces Genome-Wide DNA Methylation Profiling Using Highly Acclaimed Infinium(R) Assay |
25-Oct-2007 |
| Illumina Named as Defendant in Patent Infringement Suits |
25-Oct-2007 |
| Illumina Reports Financial Results for Third Quarter 2007 |
23-Oct-2007 |
| Illumina Launches MicroRNA Assay for Gene Expression Profiling |
22-Oct-2007 |
| Illumina to Announce Third Quarter 2007 Earnings Results on Tuesday, October 23, 2007 |
16-Oct-2007 |
| Illumina Announces Multi-Million Dollar Agreement with the University of Virginia and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
15-Oct-2007 |
| Illumina to Present at the 2007 ThinkEquity Partners and UBS Global Life Sciences Conferences |
17-Sep-2007 |
| Illumina Signs Fourth Genotyping Service Agreement with Leading UK-Based Cancer Research Group |
12-Sep-2007 |
| Illumina Announces that SNP Genetics is the First Company in Asia to Become an Illumina CSPro(TM) For Delivering High-Quality Genotyping Services |
7-Sep-2007 |
| Illumina Introduces the Infinium(R) HumanLinkage-12 Genotyping BeadChip |
6-Sep-2007 |
| Illumina to Webcast Analyst Day on September 12, 2007 |
6-Sep-2007 |
| Illumina to Present at the 2007 Thomas Weisel Partners and Bear Stearns Healthcare Conferences |
30-Aug-2007 |
| Illumina, Inc. Files Resale Registration Statement for Previously Issued Convertible Senior Notes |
13-Aug-2007 |
| Company Profile for Illumina, Inc. |
10-Aug-2007 |
| Illumina to Participate in the Leerink Swann & Company Roundtable Conference |
6-Aug-2007 |
| Illumina Introduces the Infinium(R) HumanHap550-Duo BeadChip |
2-Aug-2007 |
| Illumina Reports Financial Results for Second Quarter 2007 |
24-Jul-2007 |
| Illumina Announces Broad Commercialization of Two Sequencing-Based Applications for Gene Expression Analysis |
24-Jul-2007 |
| Illumina Announces Multi-Million Dollar Collaboration with the University of Pennsylvania, the Broad Institute, and the CARe Consortium to Develop a Customized SNP Panel for Vascular Disease |
23-Jul-2007 |
| Illumina to Announce Second Quarter 2007 Earnings Results on Tuesday, July 24, 2007 |
12-Jul-2007 |
| Mexico's National Institute of Genomic Medicine (INMEGEN) Unveils New Illumina Genotyping and Gene Expression Analysis Facility |
10-Jul-2007 |
| Illumina Commences Shipment of the Human1M BeadChip |
2-Jul-2007 |
| IntegraGen Becomes First Certified French Service Provider for Illumina GoldenGate and Infinium Genotyping |
18-Jun-2007 |
| Illumina Receives Order for 75th Genome Analyzer |
13-Jun-2007 |
| Illumina Unveils the First Industry-Hosted Controls Database for Genetic Research |
11-Jun-2007 |
| Illumina Announces Publication of the Industry's First Peer-Reviewed ChIP-Seq Studies Using Solexa(R) Technology |
8-Jun-2007 |
| Illumina to Present at the 2007 Bank of America Health Care Conference |
24-May-2007 |
| Illumina Launches New Software Support Program for Downstream Analysis of Microarray Data |
1-May-2007 |
| Illumina to Present at the 2007 Annual Deutsche Bank Securities and Robert W. Baird Growth Stock Conferences |
30-Apr-2007 |
| Illumina Infinium BeadChips Selected by Germany's National Genome Research Network to Support One of the World's Largest Genetic Disease Studies to Date |
26-Apr-2007 |
| Illumina Reports Financial Results for First Quarter 2007 |
24-Apr-2007 |
| Illumina Announces Launch of Custom Methylation Application |
16-Apr-2007 |
| Illumina to Announce First Quarter 2007 Earnings Results on Tuesday, April 24, 2007 |
13-Apr-2007 |
| Illumina Announces Consolidation of Connecticut Operations |
11-Apr-2007 |
| Illumina Technology Uncovers Genetic Risk Factors Associated with Prostate Cancer and Lou Gehrig's Disease |
2-Apr-2007 |
| Illumina Launches the BeadXpress System Targeting Research and Clinical Development Applications |
21-Mar-2007 |
| Illumina Announces Outcome of First Phase of Its Patent Litigation against Affymetrix |
13-Mar-2007 |
| Illumina Launches the Human CNV370-Duo DNA Analysis BeadChip for Copy Number Variation Research |
12-Mar-2007 |
| Illumina to Present at the Cowen and Company, Citigroup, and Lehman Brothers Conferences |
8-Mar-2007 |
| Illumina Named Senior Party in Interference Proceeding Challenging Ownership Rights for Patent Covering Affymetrix Technology |
1-Mar-2007 |
| Illumina Announces $75 Million Share Repurchase Program |
27-Feb-2007 |
| Illumina Closes $400 Million Convertible Senior Notes |
16-Feb-2007 |
| deCODE Receives Illumina CSPro(TM) Certification for Delivering Top Quality SNP Genotyping Services |
14-Feb-2007 |
| Asuragen Becomes the First Certified Service Provider for Illumina Gene Expression Profiling |
14-Feb-2007 |
| Illumina Prices $350 Million Convertible Senior Notes |
13-Feb-2007 |
| Researchers Announce ''Breakthrough Discovery'' in Type-2 Diabetes Using Illumina's HumanHap300 and Human-1 Genotyping BeadChips |
13-Feb-2007 |
| Illumina to Offer $325 Million Convertible Senior Notes |
12-Feb-2007 |
| Illumina Announces Technical Breakthroughs at the 2007 Advances in Genome Biology and Technology Conference |
12-Feb-2007 |
| Illumina to Present at the Annual Deutsche Bank Securities 2007 Small Cap Growth Conference |
8-Feb-2007 |
| Illumina Reports Financial Results for Fourth Quarter 2006 |
1-Feb-2007 |
| Illumina to Present at the Annual Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference |
31-Jan-2007 |
| Illumina Announces the Completion of Its Acquisition of Solexa |
26-Jan-2007 |
| Illumina Unveils Industry's Most Comprehensive Whole-Genome DNA Analysis Solution |
10-Jan-2007 |
| Illumina Introduces High-Throughput DNA Methylation Profiling on the BeadArray(TM) Platform |
10-Jan-2007 |
| Illumina Announces Collaboration with Established Clinical Research Institute to Develop Molecular Diagnostics for Complex Diseases |
9-Jan-2007 |
| Illumina and the Children's Hospital of Eastern Ontario Embark on a Research Collaboration for the Development of Molecular Diagnostics for Newborn Screening |
8-Jan-2007 |
| Illumina to Present at the 25th Annual JP Morgan Healthcare Conference |
22-Dec-2006 |
| Illumina Obtains HSR Clearance to Acquire Solexa |
21-Dec-2006 |
| Illumina and Solexa Announce Date of Special Meetings |
19-Dec-2006 |
| GlaxoSmithKline Purchases Illumina's HumanHap550 BeadChips for Large-Scale Whole-Genome Association Studies |
19-Dec-2006 |
| Science and The Lancet Publish Results Using Illumina's HumanHap300 BeadChip |
5-Dec-2006 |
| Illumina to Present at 18th Annual Piper Jaffray Health Care Conference |
20-Nov-2006 |
| The Genome Institute of Singapore, in Partnership with a Top-Ten Pharmaceutical Company, Selects Illumina's HumanRef-8 BeadChip for Gene Expression Profiling |
16-Nov-2006 |
| Illumina Technology Selected by Johns Hopkins University School of Medicine for Major Public Health Study |
15-Nov-2006 |
| Illumina Signs Definitive Agreement to Acquire Solexa |
13-Nov-2006 |
| Illumina to Present at the Lehman Brothers Third Annual Small Cap Conference |
9-Nov-2006 |
| Illumina Genotyping Technology Selected by Erasmus MC for Europe's Largest Cohort Study |
8-Nov-2006 |
| Illumina to Present at the 7th Annual Cowen and Company Global Health Care Conference |
1-Nov-2006 |
| Illumina Technology Selected by Amgen for Landmark Women's Health Study with Brigham & Women's Hospital |
25-Oct-2006 |
| Illumina Reports Financial Results for Third Quarter 2006 |
17-Oct-2006 |
| Top Five Pharmaceutical Company Purchases Large-Scale Genetic Analysis System from Illumina |
17-Oct-2006 |
| Illumina to Host Conference Call on October 17, 2006 Following Release of Third Quarter 2006 Results |
11-Oct-2006 |
| Duke University's Center for Human Genetics Selects Illumina's Infinium HumanHap550 BeadChip for Landmark Autism Study |
4-Oct-2006 |
| Illumina Introduces World's First Multi-Sample Whole-Genome Genotyping BeadChips |
25-Sep-2006 |
| Illumina Introduces RatRef-12 Whole-Genome Expression BeadChip; Researchers Now Have Access to a Full Suite of Multi-Sample, Whole-Genome Expression Arrays at Industry-Best Pricing |
21-Sep-2006 |
| Illumina to Webcast Presentation at UBS Global Life Sciences Conference |
20-Sep-2006 |
| CORRECTING and REPLACING Federal MicroArray Quality Control Study Addresses Intercompatability of Microarray Gene Expression Platforms; Results Pave the Way for Researchers to Choose Platform Based on Performance, Value, Ease of |
8-Sep-2006 |
| Illumina to Webcast Presentations at Two Financial Conferences in September |
7-Sep-2006 |
| Illumina to Develop iSelect Bovine BeadChip with Three Collaborating Institutions to Genotype over 10,000 Cattle; Genome-Wide SNP Content Designed to Improve Selection for Multiple Breeds of Cattle |
24-Aug-2006 |
| Massachusetts General Hospital and Harvard Medical School Select Illumina HumanHap300 BeadChips for Whole-Genome Association Study of Amyotrophic Lateral Sclerosis |
22-Aug-2006 |
| Illumina Announces Markman Ruling in Litigation Against Affymetrix Favorable to Illumina Defenses and Counterclaims |
17-Aug-2006 |
| Illumina Announces Certified Service Provider Program for Genetic Analysis Services and Names First Participating Organizations |
9-Aug-2006 |
| Illumina Expands Services Agreement with GlaxoSmithKline to Include Infinium(TM) Genotyping with HumanHap550 BeadChips for Large-Scale Disease Association Studies |
2-Aug-2006 |
| Illumina to Webcast Presentation at Baird Oncology Conference |
26-Jul-2006 |
| Illumina and ReaMetrix to Collaborate on Molecular Diagnostics and Market Development; ReaMetrix Secures Non-Exclusive License to Market Diagnostic Panels in India |
20-Jul-2006 |
| Illumina Reports Financial Results for Second Quarter 2006; Consumables and Instrument Revenue Drive 163% Growth Over Prior-Year Quarter; Company Raises Financial Guidance for Fiscal 2006 |
18-Jul-2006 |
| Illumina to Conduct Custom Genotyping for Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
13-Jul-2006 |
| Illumina Announces HumanHap550+ and iSelect Infinium(TM) Genotyping Products; Flexible Offering Enables Design of Custom Array Content to Analyze up to 670,000 SNPs or 12 Samples on a Single BeadChip |
13-Jul-2006 |
| Illumina to Host Conference Call on July 18 Following Release of Second Quarter 2006 Results |
11-Jul-2006 |
| Illumina Introduces Sentrix(R) HumanHap650Y Genotyping BeadChip; Product Sets New Standard for SNP Density and Genomic Coverage on a Single Array; HIV among First Areas to Be Studied |
29-Jun-2006 |
| Illumina Appoints Jack Goldstein to Board of Directors |
27-Jun-2006 |
| Illumina to Webcast Presentation at Pacific Growth Life Sciences Conference |
7-Jun-2006 |
| The Children's Hospital of Philadelphia Purchases Large-Scale Illumina(R) System to Genotype Children, Study Childhood Disease and Guide Therapy |
7-Jun-2006 |
| Illumina to Webcast Presentation at Goldman Sachs Healthcare Conference |
6-Jun-2006 |
| Illumina Appoints Christian Cabou Senior Vice President and General Counsel |
31-May-2006 |
| Illumina Announces That Underwriters Have Exercised Option to Purchase an Additional 525,000 Shares of Common Stock |
24-May-2006 |
| Illumina Announces Public Offering of Common Stock |
19-May-2006 |
| Illumina and deCODE Form Alliance to Develop and Commercialize DNA-Based Diagnostics |
15-May-2006 |
| Illumina Announces Proposed Public Offering of Common Stock |
11-May-2006 |
| Shafallah Center Purchases Illumina(R) BeadLab for New Genomics Facility in Doha, Qatar; Illumina Technology Platform Enables Large-Scale Disease Association Studies |
9-May-2006 |
| Illumina to Webcast Presentation at Leerink Swann Roundtable Discussion on Life Science Tools |
3-May-2006 |
| Illumina to Webcast Presentation at Deutsche Bank Health Care Conference |
26-Apr-2006 |
| Illumina Reports Financial Results for First Quarter 2006; Strong Demand Drives 92% Quarterly Revenue Growth; Company Raises Financial Guidance for Fiscal 2006 |
18-Apr-2006 |
| Illumina Appoints Arthur L. Holden to Head Corporate and Market Development |
18-Apr-2006 |
| Illumina Introduces High-Throughput Solutions with Walkaway Automation; New AutoLoader and BeadScan Software Improve Scanning Throughput by 400% and Minimize Labor Costs |
17-Apr-2006 |
| Illumina to Conduct Large-Scale Genotyping for UK-Based Research Groups Studying Molecular Basis of Prostate Cancer |
11-Apr-2006 |
| Illumina Expects to Exceed Financial Guidance for the First Quarter of 2006; Management to Host Conference Call on April 18 Following Release of First Quarter 2006 Results |
6-Apr-2006 |
| Illumina Introduces HumanHap550 Genotyping BeadChip; New HumanHap BeadChips Expand Genomic Coverage with Industry-Leading Performance |
28-Mar-2006 |
| Illumina Expands GoldenGate(R) Genotyping Portfolio with Launch of Three Content Products and Reduced-Complexity Array Matrix; Panels Target Cancer and Mouse Genetic Linkage |
7-Mar-2006 |
| Illumina to Webcast Presentation at SG Cowen Health Care Conference |
28-Feb-2006 |
| Center for Inherited Disease Research (CIDR) Standardizes on Illumina Technology for Genome-Wide Association Genotyping; New Offering Leverages CIDR's BeadLab Infrastructure to Supplement Custom SNP Genotyping Services |
15-Feb-2006 |
| Illumina Awarded Genotyping Contract by SAIC-Frederick, Inc. for Cancer Genetics Marker Susceptibility (CGEMS) Study |
14-Feb-2006 |
| Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2005; Revenue Growth of 56% Over Prior Year Yields Profitable Fourth Quarter |
1-Feb-2006 |
| Illumina Appoints Matt Posard to Lead Worldwide Marketing |
1-Feb-2006 |
| Illumina to Host Conference Call on February 1 Following Release of Fourth Quarter and Fiscal Year 2005 Results |
19-Jan-2006 |
| Illumina Announces Agreement for Sale of Production-Scale Genetic Analysis Laboratory |
19-Jan-2006 |
| Genizon BioSciences Converts to Illumina Genotyping Technology for Disease Association Research; Data from Illumina BeadChips and Infinium(TM) Assay to Accelerate Development of Genizon GeneMaps |
12-Jan-2006 |
| North Shore-Long Island Jewish Health System to Use Illumina Whole-Genome Genotyping Solutions to Support Study of Inflammatory Bowel Disease |
12-Jan-2006 |
| Center for Inherited Disease Research (CIDR) to Use Illumina Whole-Genome Genotyping Solutions to Support Study for Finland-United States Type 2 Diabetes Collaboration |
11-Jan-2006 |
| Illumina Now Shipping HumanHap300 BeadChips for Genome-Wide Disease Association Studies; Infinium(TM) Assay Sets New Standard for Performance and Data Quality |
10-Jan-2006 |
| Illumina to Webcast Presentation at JP Morgan Healthcare Conference |
4-Jan-2006 |
| Illumina Advances Genetic Analysis of Cancer with Powerful Tools for Characterizing Chromosomal Changes; Infinium(TM) Whole-Genome Genotyping Data to Help Identify Potential Diagnostic and Therapeutic Targets |
15-Dec-2005 |
| Illumina Conducting Large-Scale Poultry Genotyping Project for Aviagen; Results to Pave Way for Improved Breeding Technologies |
16-Nov-2005 |
| Illumina to Conduct Large-Scale Genotyping for UK-Based Research Groups Studying Molecular Basis of Colorectal Cancer; Study Designed to Understand Genetic Susceptibility, Mechanisms of Disease Progression, and Cancer Therapy Management |
8-Nov-2005 |
| Illumina to Webcast Presentation at SG Cowen Health Care Conference |
1-Nov-2005 |
| PharmacoDesign Purchases Illumina Genotyping Solutions for Pharmacogenomics Research; Illumina to Gain Exclusive, Licensed Access to Biomarkers Discovered Through Disease Studies |
25-Oct-2005 |
| Illumina Challenges Ownership Rights for Patent Covering ParAllele Technology Acquired by Affymetrix |
24-Oct-2005 |
| Illumina Reports Financial Results for Third Quarter 2005; Revenue Increases 44% Over Third Quarter 2004 |
24-Oct-2005 |
| PARC Team Purchases Illumina Genotyping Solutions for Study of Pharmacogenomics of Cardiovascular Disease; Multi-Phase Study Aims to Identify Genetic Markers and Determine Effect of Specific Genotypes on Individual Response to Statins |
20-Oct-2005 |
| Illumina to Host Conference Call on October 24 Following Release of Third Quarter 2005 Results |
17-Oct-2005 |
| Illumina to Develop Custom, Multi-Sample Genotyping BeadChip for the Wellcome Trust Sanger Institute; Custom SNP BeadChip to Be Used As Part of the Wellcome Trust Case-Control Consortium for Understanding Disease Associations |
28-Sep-2005 |
| Illumina and GlaxoSmithKline Sign Agreement for Large-Scale Genotyping Studies |
22-Sep-2005 |
| Illumina to Webcast Presentation at UBS Global Life Sciences Conference |
21-Sep-2005 |
| Max-Planck Institute Of Psychiatry To Use Illumina Whole-Genome Arrays For Large-Scale Genotyping Studies |
20-Sep-2005 |
| National Cancer Institute Purchases Production-Scale Beadlab From Illumina For Array-Based Genetic Analysis |
1-Sep-2005 |
| Illumina Announces Worldwide Availability Of Multi-Sample, Genome-Wide Expression Microarrays For Mouse Genome |
31-Aug-2005 |
| Illumina Reports Financial Results For Second Quarter 2005 |
26-Jul-2005 |
| Illumina to Host Conference Call on July 26 Following Release of Second Quarter 2005 Results |
13-Jul-2005 |
| Illumina Holds Annual Meeting of Shareholders |
29-Jun-2005 |
| Illumina Initiates Shipment Of Whole-Genome Genotyping Beadchips |
28-Jun-2005 |
| Illumina to Present at Invitrogen Investor Meeting |
14-Jun-2005 |
| Illumina Launches Industry's First SNP Assay Panels for Fine Mapping Disease-Associated Genetic Variants in the Major Histocompatability Complex (MHC) Region of the Genome |
7-Jun-2005 |
| Illumina to Webcast Presentation at Goldman Sachs Global Healthcare Conference |
7-Jun-2005 |
| Illumina to Webcast Presentation at Pacific Growth Equities Life Sciences Conference |
25-May-2005 |
| Illumina Promotes Kirk Malloy to Vice President of Customer Solutions |
12-May-2005 |
| Illumina Appoints Christian Henry As Chief Financial Officer |
3-May-2005 |
| Illumina Reports Financial Results for First Quarter 2005 |
27-Apr-2005 |
| Illumina To Host Conference Call On April 27 Following Release Of First Quarter 2005 Results |
19-Apr-2005 |
| Illumina Appoints Scott Kahn to Lead Information Technology |
14-Apr-2005 |
| Illumnia Appoints Dr. Paul Grint To Board of Directors |
12-Apr-2005 |
| Illumina Completes Cyvera Acquisition |
11-Apr-2005 |
| Illumina Announces Worldwide Availabiliy Of Multi-Sample, Genome-Wide Expression Microarrays |
15-Mar-2005 |
| Illumina Announces Plan To Release One-Million-SNP Genotyping BeadChips By June 2006 |
15-Mar-2005 |
| Illumina to Webcast Presentation at SG Cowen Health Care Conference |
8-Mar-2005 |
| Illumina Signs Definitive Agreement to Acquire CyVera Corporation |
22-Feb-2005 |
| Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2004 |
22-Feb-2005 |
| Illumina to Host Conference Call Following Release of Fourth Quarter and Fiscal Year 2004 Results |
10-Feb-2005 |
| Illumina Names William Rastetter Chairman Of Board And Appoints John Stuelpnagel Chief Operating Officer |
27-Jan-2005 |
| Illumina Launches DASL™ Assay And Cancer Panel For Gene Expression Profiling Of Paraffin-Embedded Samples |
13-Jan-2005 |
| Invitrogen and Illumina Announce Strategic Alliance Combining DNA Synthesis, Distribution and Marketing Strengths For Global Life Sciences Customers |
20-Dec-2004 |
| Illumina Begins Shipping New Mouse Genome Oligo Set |
14-Dec-2004 |
| Illumina Successful in Reducing Damages on Appeal of Employment Lawsuit |
6-Dec-2004 |
| Illumina To Webcast Presentation at SG Cowen Conference |
9-Nov-2004 |
| Illumina Reports Financial Results For Third Quarter 2004 |
19-Oct-2004 |
| Illumina to Webcast Presentation At UBS Warburg Conference |
27-Sep-2004 |
| Illumina To Conduct Large-Scale Genotyping Study for North American Rheumatoid Arthritis Consortium |
16-Sep-2004 |
| Illumina Completes Sale of San Diego Facilities for $42 Million and Enters Into Long-Term Leaseback Arrangement |
19-Aug-2004 |
| Illumina and Applera Agree to Settle All Disputes |
19-Aug-2004 |
| Galileo Genomics Purchases Illumina Beadstation Platforms to Fine Map Candidate Regions for At Least Five Disease Gene Discovery Programs |
19-Aug-2004 |
| Illumina to Perform Large-Scale Mouse Genotyping Study for the Wellcome Trust Centre |
12-Aug-2004 |
| Illumina Receives $1.2 Million Grant from the National Institutes of Health to Continue Research on Bead-Based Proteomic Arrays |
11-Aug-2004 |
| Illumina Appoints Karin Eastham to Board of Directors |
2-Aug-2004 |
| Illumina to Webcast Presentation at Baird Small Cap Conference |
27-Jul-2004 |
| Illumina Notified of Patent Lawsuit |
27-Jul-2004 |
| Genomas and Illumina Form Strategic Alliance on Physiogenomics of Metabolic Syndrome |
20-Jul-2004 |
| Illumina Reports Financial Results for Second Quarter 2004 |
14-Jul-2004 |
| Illumina to Install Genotyping BeadLab at UCLA for New Southern California Genotyping Consortium |
1-Jul-2004 |
| University of Southern California Purchases Production-Scale SNP Genotyping BeadLab from Illumina |
8-Jun-2004 |
| Illumina to Raise $30 Million in Registered Offering |
11-May-2004 |
| Illumina Extends BeadArray Technology to Address Wider Range of SNP Genotyping Projects |
4-May-2004 |
| Illumina to Webcast Presentation at Goldman Sachs Healthcare Conference |
27-Apr-2004 |
| Illumina Announces 100,000 SNPs on a Single BeadChip |
21-Apr-2004 |
| Illumina Reports Financial Results for First Quarter 2004 |
20-Apr-2004 |
| Illumina Announces Breakthrough Pricing for Whole-Genome Expression Arrays |
18-Apr-2004 |
| Illumina Begins Shipment of BeadStation 500G Benchtop Genotyping System |
15-Apr-2004 |
| Illumina to Webcast Presentation at SG Cowen Health Care Conference |
26-Feb-2004 |
| France's Centre National de Genotypage Purchases Production-Scale SNP Genotyping BeadLab from Illumina |
25-Feb-2004 |
| Illumina Advances Whole-Genome Expression Analysis With Announcement Of Six Human Genomes On A Single BeadChip |
14-Jan-2004 |
| Illumina Announces BeadLab Installation At University Of Tokyo |
12-Jan-2004 |
| Illumina Appoints Daniel Bradbury to Board of Directors |
9-Jan-2004 |
| Illumina to Webcast Presentation at JPMorgan Healthcare Conference |
6-Jan-2004 |
| San Diego Court Directs Illumina Dispute with Applera to Arbitration |
19-Dec-2003 |
| Illumina Accelerates Genomic Research by Lowering Cost of Oligonucleotides to $0.11 Per Base |
2-Dec-2003 |
| Illumina Announces Benchtop SNP Genotyping System |
5-Nov-2003 |
| Illumina to Webcast Presentation at UBS Global Life Science Conference |
19-Sep-2003 |
| Illumina Launches Gene Expression Product Line On SentrixTM Multi-Array Platforms |
16-Sep-2003 |
| Illumina Completes Installation of Production-Scale SNP Genotyping BeadLab at the Whitehead Institute |
15-Sep-2003 |
| Illumina Announces Powerful SNP Linkage Mapping Panel and Fast-Track Genotyping Service |
19-Aug-2003 |
| Johns Hopkins University Purchases Production-Scale SNP Genotyping BeadLab From Illumina |
9-Jul-2003 |
| Top Research Institution Chooses the BeadLab Solution from Illumina |
8-Jul-2003 |
| Shanghai's National Center for Biochip Technology Purchases Production-Scale SNP Genotyping BeadLab from Illumina |
30-Jun-2003 |
| Illumina Announces SentrixTM BeadChip Platform |
12-Jun-2003 |
| Illumina to Webcast Presentation at the Goldman Sachs 24th Annual Global Healthcare Conference |
3-Jun-2003 |
| The Wellcome Trust Sanger Institute Purchases Production-Scale SNP Genotyping Solution from Illumina |
17-Feb-2003 |
| New Oligo Reference Set to Feature Publicly Available Sequence Information and Industry-Leading Pricing |
5-Feb-2003 |
| Genome Quebec Innovation Centre Purchases Production-Scale SNP Genotyping Solution from Illumina |
9-Jan-2003 |
| Illumina Expands Portfolio of Standard SNP Genotyping Products and Services |
8-Jan-2003 |
| Illumina To Webcast Presentation At JPMorgan H&Q Healthcare Conference |
3-Jan-2003 |
| Illumina Notifies Applied Biosystems of Breach of Joint Development Agreement |
5-Dec-2002 |
| Illumina Names Tristan Orpin to Lead Worldwide Sales |
3-Dec-2002 |
| Illumina To Provide Oligonucleotides for Very Large-Scale Genomics Study at Cold Spring Harbor Laboratory |
2-Dec-2002 |
| Illumina Selected by the National Institutes of Health to Participate in the International HapMap Project |
29-Oct-2002 |
| Illumina Appoints Susan Eddins to Head Worldwide Marketing |
1-Oct-2002 |
| Illumina Receives $9 Million from the National Institutes of Health for Large-Scale Genotyping of the Human Genome |
30-Sep-2002 |
| Illumina To Conduct Large-Scale SNP Genotyping Services For GlaxoSmithKline |
19-Sep-2002 |
| Illumina Signs Genotyping Agreement with the University of Cambridge, UK |
27-Aug-2002 |
| Illumina Signs SNP Genotyping Agreement with The Wellcome Trust Sanger Institute |
24-Jul-2002 |
| Illumina Will Appeal Employment Lawsuit Verdict |
12-Jul-2002 |
| Illumina Launches Integrated, High-Throughput SNP Genotyping System |
8-Jul-2002 |
| Illumina Introduces SNP-Based Linkage Panel for High-Throughput Genotyping |
12-Jun-2002 |
| ILLUMINA SIGNS GENOTYPING SERVICES AGREEMENT WITH THE UNIVERSITY OF NORTH CAROLINA (UNC) AT CHAPEL HILL |
30-May-2002 |
| Illumina Doubles Oligator DNA Synthesis Capacity and Launches $0.16 Per Base Oligo Pricing |
20-May-2002 |
| Illumina Receives $1.0 Million Phase 2 SBIR Grant from The National Institutes of Health to Develop Matrixed Microarrays |
10-May-2002 |
| Illumina Promotes John Stuelpnagel to Senior Vice President |
10-May-2002 |
| Illumina Signs Genotyping Services Agreement With Placer |
2-May-2002 |
| Illumina Signs Genotyping Services Agreement with University of California, San Diego and San Diego VA Healthcare System |
25-Apr-2002 |
| Illumina and Oxagen to Collaborate on Fine Mapping of SNP Loci in Genetic Linkage Regions |
19-Mar-2002 |
| Illumina Receives $1.2 Million Phase 2 Grant from National Cancer Institute to Develop Microarrays for Protein Profiling |
11-Mar-2002 |
| Illumina Licenses Confocal Scanning Patents From Amersham Biosciences |
19-Feb-2002 |
| Illumina Signs Genotyping Services Agreement with Investigators at Boston University |
28-Jan-2002 |
| Illumina Signs Genotyping Services Agreement With Johns Hopkins Medical University |
8-Jan-2002 |
| Illumina Announces Webcast of Presentation at JPMorgan H&Q Healthcare Conference |
3-Jan-2002 |
| Illumina Triples Oligator Oligonucleotide Synthesis Manufacturing Capacity |
2-Jan-2002 |
| Illumina Signs Genotyping Services Agreement with GlaxoSmithKline |
29-Jun-2001 |
| Scott Greer Joins Illumina Board of Directors |
4-Jun-2001 |
| Illumina, Inc. Adopts Stockholder Rights Plan |
4-May-2001 |
| Illumina Announces Webcast of Presentation At Thomas Weisel Partners' Healthcare Tailwinds Conference |
3-Apr-2001 |
| Illumina Formalizes Collaboration With Chevron to Develop BeadArrayTM Sensors for Chemical Detection Applications |
27-Feb-2001 |
| Illumina Commissions Oligonucleotide Synthesis Facility for BeadArray Production and SNP Genotyping Services |
8-Jan-2001 |
| Illumina Names David Douglas as Vice President of Manufacturing |
5-Jan-2001 |
| Illumina Names Arnold Oliphant to Lead Scientific Operations |
11-Oct-2000 |
| Illumina Makes Appointments to Management Team |
12-Apr-2000 |
| Illumina Raises $28 Million in Private Equity Financing |
10-Jan-2000 |
| PE Biosystems and Illumina Announce Strategic Collaboration to Develop and Commercialize High-Throughput DNA Array Systems |
9-Nov-1999 |
| Illumina Appoints Jay Flatley as President and CEO |
23-Sep-1999 |
| Illumina Raises $8.5 Million, Expands Scientific Management Team, Establishes Scientific Advisory Board |
17-Dec-1998 |
| Illumina Licenses Core Technology, Completes Seed Financing, Recruits Key Managers |
5-Aug-1998 |
 |
